HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A 68-year-old phenotypically male patient with 21-hydroxylase deficiency and concomitant adrenocortical neoplasm producing testosterone and cortisol.

Abstract
The steroidogenic enzyme 21-hydroxylase is necessary for the synthesis of both glucocorticoids and mineralocorticoids. 21-hydroxylase is a cytochrome P-450 enzyme and is encoded by the gene CYP21A2. Here we report a 68-year-old phenotypically 'male' but genetically female patient with 21-hydroxylase deficiency (21OHD) and the concomitant virilizing adrenocortical carcinoma. This patient grew up as a male and has not encountered any episodes of adrenal insufficiency without glucocorticoid replacement in his lifetime. A chromosome test at admission, however, identified the 46, XX karyotype, and serum 17-hydroxyprogesterone and urine pregnanetriolone and 11β-hydroxyandrostendione were all elevated, consistent with 21OHD. Moreover, serum testosterone was 1.90 ng/ml, much higher than the female standard levels, and serum cortisol was 5.7 µg/ml, slightly lower than standard levels. Genetic analysis identified the patient as a heterozygote of the two pathogenic mutations in the CYP21A2 gene: IVS2-13C(A)>G and R356W. Magnetic resonance imaging (MRI) revealed the presence of left adrenal tumor measuring 6 cm, which was subsequently diagnosed as adrenocortical carcinoma based on the criteria of Weiss. Immunohistochemical analysis of the tumor specimens revealed the expression of various enzymes involved in testosterone production, including 3β-hydroxysteroid dehydrogenase, 17α-hydroxylase/17,20-lyase, and 17β-hydroxysteroid dehydrogenase. Importantly, the expression of immunoreactive 21-hydroxylase was detected in these tumor cells. The levels of adrenal tumor-derived steroid metabolites were all markedly decreased following the surgery. This is the first report on a virilized 21OHD patient associated with the adrenocortical tumor that produces testosterone. Moreover, the concomitant adrenocortical tumor may ameliorate adrenocortical insufficiency by producing cortisol.
AuthorsMasayuki Hayashi, Yuko Kataoka, Yoshihisa Sugimura, Fumiko Kato, Maki Fukami, Tsutomu Ogata, Keiko Homma, Tomonobu Hasegawa, Yutaka Oiso, Hironobu Sasano, Hiroshi Tanaka
JournalThe Tohoku journal of experimental medicine (Tohoku J Exp Med) Vol. 231 Issue 2 Pg. 75-84 (10 2013) ISSN: 1349-3329 [Electronic] Japan
PMID24077358 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Pregnanetriol
  • Testosterone
  • Androstenedione
  • 11-hydroxyandrostenedione
  • pregnanetriolone
  • 17-alpha-Hydroxyprogesterone
  • Hydrocortisone
Topics
  • 17-alpha-Hydroxyprogesterone (blood)
  • Adrenal Cortex Neoplasms (complications, metabolism)
  • Adrenal Hyperplasia, Congenital (complications)
  • Aged
  • Androstenedione (analogs & derivatives, urine)
  • Base Sequence
  • Female
  • Gas Chromatography-Mass Spectrometry
  • Humans
  • Hydrocortisone (blood, metabolism)
  • Immunohistochemistry
  • Japan
  • Magnetic Resonance Imaging
  • Male
  • Molecular Sequence Data
  • Pregnanetriol (analogs & derivatives, urine)
  • Sequence Analysis, DNA
  • Testosterone (blood, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: